Haisco Pharmaceutical Group (002653.SZ) plans to establish wholly-owned subsidiaries in the British Virgin Islands and the Cayman Islands respectively.

Haisco Pharmaceutical Group (002653.SZ) announced that the 18th meeting of the fifth board of directors approved the proposal to establish wholly-owned subsidiaries in the British Virgin Islands and Cayman Islands. The company has agreed to establish a wholly-owned subsidiary named HEXGEN HOLDINGS LIMITED in the British Virgin Islands and a wholly-owned subsidiary named HEXGEN PHARMACEUTICAL GROUP LIMITED (proposed name, Chinese name: Haisco Jin Pharmaceutical Group Limited) in Cayman Islands.